Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$208M |
| 2 |
Lowe's Companies
LOW
|
+$198M |
| 3 |
American Tower
AMT
|
+$161M |
| 4 |
Lennar Class A
LEN
|
+$150M |
| 5 |
British American Tobacco
BTI
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$208M |
| 2 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$177M |
| 3 |
Crown Castle
CCI
|
+$168M |
| 4 |
Walmart Inc
WMT
|
+$167M |
| 5 |
Entergy
ETR
|
+$157M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.75% |
| 2 | Technology | 13.18% |
| 3 | Healthcare | 11.51% |
| 4 | Industrials | 10.45% |
| 5 | Consumer Discretionary | 9.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Barings BDC
BBDC
$989M
| $1.01M | ﹤0.01% |
70,847
+24,313
| +52% | +$367K |
|
2502
Theriva Biologics
TOVX
$10.9M
| $1.01M | ﹤0.01% |
124
-23
| -16% | -$133K |
|
2503
CALL
Integra LifeSciences
IART
$1.31B
| $1.01M | ﹤0.01% |
+20,000
| New | +$1.03M |
|
2504
iShares Russell 1000 Growth ETF
IWF
$125B
| $998K | ﹤0.01% |
31,912
-1,820
| -5% | -$55.7K |
|
|
CVON
2505
DELISTED
ConvergeOne Holdings, Inc. Class A Common Stock
CVON
| $998K | ﹤0.01% |
102,326
-2,600
| -2% | -$25.3K |
|
2506
CALL
Illumina
ILMN
$34B
| $996K | ﹤0.01% |
+5,140
| New | +$957K |
|
|
2507
PUT
Illumina
ILMN
$34B
| $996K | ﹤0.01% |
5,140
+2,056
| +67% | +$383K |
|
|
NXEO
2508
DELISTED
Nexeo Solutions, Inc. Common Stock
NXEO
| $995K | ﹤0.01% |
+136,353
| New | +$1.04M |
|
2509
Alico
ALCO
$304M
| $993K | ﹤0.01% |
+29,084
| New | +$924K |
|
|
Y
2510
DELISTED
Alleghany Corp
Y
| $992K | ﹤0.01% |
1,790
-653
| -27% | -$381K |
|
2511
Unifirst Corp
UNF
$5.21B
| $989K | ﹤0.01% |
6,526
-21,283
| -77% | -$3.01M |
|
|
OMED
2512
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $988K | ﹤0.01% |
218,490
-64,175
| -23% | -$260K |
|
|
JONE
2513
DELISTED
Jones Energy, Inc.
JONE
| $986K | ﹤0.01% |
25,684
+14,935
| +139% | +$399K |
|
2514
RCI Hospitality Holdings
RICK
$232M
| $985K | ﹤0.01% |
+39,786
| New | +$949K |
|
|
SPNE
2515
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $985K | ﹤0.01% |
87,831
-98,733
| -53% | -$1.14M |
|
|
HLTH
2516
DELISTED
Nobilis Health Corp.
HLTH
| $985K | ﹤0.01% |
656,787
-70,031
| -10% | -$111K |
|
|
AKTS
2517
DELISTED
Akoustis Technologies Inc
AKTS
| $983K | ﹤0.01% |
150,714
+46,944
| +45% | +$327K |
|
|
MCBC
2518
DELISTED
Macatawa Bank Corp
MCBC
| $981K | ﹤0.01% |
95,639
-40,591
| -30% | -$386K |
|
|
FPO
2519
DELISTED
First Potomac Realty Trust
FPO
| $981K | ﹤0.01% |
+88,048
| New | +$980K |
|
2520
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.84B
| $979K | ﹤0.01% |
30,264
-51,688
| -63% | -$1.62M |
|
|
GOGL
2521
DELISTED
Golden Ocean Group
GOGL
| $978K | ﹤0.01% |
124,690
-2,020
| -2% | -$16.2K |
|
2522
AeroVironment
AVAV
$7.49B
| $976K | ﹤0.01% |
+18,026
| New | +$767K |
|
2523
Vanguard Energy ETF
VDE
$10.6B
| $976K | ﹤0.01% |
10,434
+7,661
| +276% | +$680K |
|
2524
Globus Medical
GMED
$11.1B
| $975K | ﹤0.01% |
32,813
-4,020
| -11% | -$123K |
|
|
STDY
2525
DELISTED
SteadyMed Ltd
STDY
| $972K | ﹤0.01% |
290,000
+41,207
| +17% | +$219K |
|
Similar funds
Israel Englander's Q3 2017 Portfolio in Review
As of Q3 2017, Israel Englander held 4,198 positions worth $65.6B, up 17% from $56.1B the previous quarter. Its ten largest holdings account for 7.8% of the portfolio.
Israel Englander deployed $6.37B of net new capital in Q3 2017, opening 794 new positions and adding to 1,441 existing holdings. Its largest new stake was Northern Trust: 1,591,041 shares worth $146M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Gilead Sciences, an estimated $208M trimmed.
- Israel Englander's largest Q3 2017 buy was Northern Trust: 1,591,041 shares worth $146M.
- Israel Englander added most to Salesforce in Q3 2017, an estimated $208M increase.
- Israel Englander's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $208M.
- Israel Englander fully exited CONCHO RESOURCES INC. in Q3 2017, selling an estimated $177M.
- Israel Englander's ten largest holdings make up 7.8% of its $65.6B portfolio in Q3 2017.
- Israel Englander opened 794 new positions and closed 737 in Q3 2017.
- Israel Englander's portfolio value rose 17% quarter-over-quarter to $65.6B.
Based on Millennium Management's 13F filing for Q3 2017, filed 14 Nov 2017.